靶向RUNX1的tFNA递送siRNA:通过Dll4/Notch1信号抑制视网膜新生血管并恢复血管
研究评估四面体框架核酸(tFNA)递送靶向RUNX1的小干扰RNA(siRUNX1)抑制视网膜新生血管(RNV)并经Dll4/Notch1通路恢复血管完整性的效果。体外缺氧条件下tFNAs-siRUNX1抑制内皮细胞增殖、迁移和成管;小鼠氧诱导视网膜病变(OIR)和激光诱导脉络膜新生血管(CNV)模型中减少新生血管、无灌注区和血管渗漏。机制涉及Dll4/Notch1通路调节及Bcl-2/Bax通路减少内皮细胞凋亡,作者认为其有望成为抗VEGF治疗的潜在替代方案。
要点
- tFNAs-siRUNX1在体外缺氧条件下抑制内皮细胞增殖、迁移和成管。
- OIR和CNV小鼠模型中tFNAs-siRUNX1减少新生血管、无灌注区和血管渗漏。
- 机制涉及Dll4、Notch1、Hes1降低和Nts升高,并经Bcl-2/Bax通路减少内皮细胞凋亡。
核心结论
- 作者认为tFNAs-siRUNX1是靶向RNV、抑制新生血管并恢复视网膜血管完整性的有前景递送系统,为抗VEGF治疗提供潜在替代方案。
研究设计与样本
- 体外研究:tFNAs与tFNAs-siRUNX1经单链DNA退火合成,PAGE与高效毛细管电泳表征;人脐静脉内皮细胞在缺氧条件下处理,荧光显微镜与流式细胞术评估细胞摄取,EdU增殖、成管和划痕愈合实验评估血管生成。
- 体内研究:使用小鼠氧诱导视网膜病变(OIR)和激光诱导脉络膜新生血管(CNV)模型,行光学相干断层扫描(OCT)和眼底荧光血管造影成像。
- 基因和蛋白表达经RT-PCR和Western blotting分析,聚焦Dll4/Notch1通路和凋亡标志物。
主要发现
- tFNAs-siRUNX1在体外有效抑制内皮细胞增殖、迁移和成管。
- OIR和CNV模型中tFNAs-siRUNX1减少新生血管、无灌注区和血管渗漏。
- 机制涉及Dll4/Notch1通路调节,Dll4、Notch1和Hes1降低而Nts表达升高。
- tFNAs-siRUNX1经Bcl-2/Bax通路减少内皮细胞凋亡。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To assess the efficacy of tetrahedral framework nucleic acids (tFNAs) as a delivery system for small interfering RNA (siRNA) targeting RUNX1 (siRUNX1) in inhibiting retinal neovascularization (RNV) and restoring vascular integrity via the Dll4/Notch1 signaling pathway. METHODS: tFNAs and tFNAs-siRUNX1 were synthesized using annealing of single-stranded DNAs and characterized by PAGE and high-performance capillary electrophoresis. Human umbilical vein endothelial cells were treated under hypoxic conditions with tFNAs-siRUNX1, and cellular uptake was evaluated using fluorescence microscopy and flow cytometry. Angiogenesis was assessed through EdU proliferation, tube formation, and wound-healing assays. In vivo experiments used oxygen-induced retinopathy (OIR) and laser-induced choroidal neovascularization (CNV) models in mice, with subsequent imaging by optical coherence tomography (OCT) and fundus fluorescence angiography. Gene and protein expression were analyzed by RT-PCR and Western blotting, focusing on the Dll4/Notch1 pathway and apoptosis markers. RESULTS: tFNAs-siRUNX1 effectively inhibited endothelial cell proliferation, migration, and tube formation in vitro. In OIR and CNV models, it reduced neovascularization, nonperfusion areas, and vascular leakage. The mechanism involved modulation of the Dll4/Notch1 pathway, with decreased Dll4, Notch1, and Hes1 and increased Nts expression. tFNAs-siRUNX1 also reduced endothelial cell apoptosis via the Bcl-2/Bax pathway. CONCLUSIONS: tFNAs-siRUNX1 is a promising delivery system for targeting RNV, inhibiting neovascularization, and restoring retinal vascular integrity, providing a potential therapeutic alternative to anti-VEGF treatments.
引用
- Zhou X, Xu X, Wang Q, et al. Targeted siRNA Delivery Against RUNX1 Via tFNA: Inhibiting Retinal Neovascularization and Restoring Vessels Through Dll4/Notch1 Signaling. Invest Ophthalmol Vis Sci. 2025. PMID: 40105819. doi:10.1167/iovs.66.3.39
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。